| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e72cccf41f0b6a4dfe2745d6a0153d01 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-20022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56972
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 |
| filingDate |
2022-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24cee7602f25eceb2f41e752ba4d2f54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99b6eac44e7a3b330d08a0e9467b0a4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_289b512b54c095a776f572b6bc55870f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a084150c29e8fc851c836f5c0bec39c2 |
| publicationDate |
2022-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022148455-A1 |
| titleOfInvention |
Identification and uses of peptide sequences of sars-cov-2 t cell and b cell epitopes |
| abstract |
The present disclosure identifies a set of T cell and B cell epitopes derived from Severe Acute Respiratory Syndrome Coronavirus 1 (SARS-CoV-1) and their use in designing vaccines against SARS-CoV-2. A method for eliciting an immune response for prophylactic or therapeutic application using the T cell and/or B cell epitopes is described. Further disclosed are SARS-CoV-2-specific polypeptides, nucleic acids, host cells, and corresponding compositions for eliciting or measuring an immune response to SARS-CoV-2 and/or other coronaviruses. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022268916-A3 |
| priorityDate |
2021-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |